Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1450421
European Journal of Endocrinology, Vol 145, Issue 4, 421-427
Copyright © 2001 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miedlich, S
Right arrow Articles by Paschke, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miedlich, S
Right arrow Articles by Paschke, R

Articles

Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism

S Miedlich, P Lamesch, A Mueller, and R Paschke

III. Medical Department, University of Leipzig, Leipzig, Germany.

OBJECTIVE: Recent studies have shown an influence of the calcium-sensing receptor variant A986S on the serum calcium concentration, suggesting that this genetic variant could be a candidate for various bone and mineral disorders. The intention of this study was therefore to investigate the frequency of the described calcium-sensing receptor variants A986S, R990G and Q1011E in patients with primary hyperparathyroidism to test the hypothesis as to whether these variants represent risk factors for the development of primary hyperparathyroidism. DESIGN: Fifty patients with primary hyperparathyroidism were included in the study. One hundred and two healthy blood donors served as controls. METHODS: Detection of the genetic variants A986S, R990G and Q1011E was done by direct sequencing of exon 7 of the calcium-sensing receptor in leucocyte DNA. RESULTS: The heterozygous variant A986S was found in 34% (17 of 50) of the healthy age- and sex-matched controls and 40% (20 of 50) of the patients with primary hyperparathyroidism. This difference was not statistically significant (P=0.68). However, in male patients the heterozygous variant A986S was found more frequently (67%, 6 of 9) than in male controls (20%, 2 of 10, P=0.07). The variants R990G and Q1011E were found less frequently (8-20%) in patients and controls without significant differences between the groups. Patients with the heterozygous variant Q1011E had significantly higher serum calcium and parathyroid hormone levels than patients with the wild-type variant (P<0.01). There was no correlation of serum calcium (total and corrected for albumin) with the calcium sensing receptor variant A986S in 102 healthy blood donors (P=0.45). CONCLUSIONS: The calcium-sensing receptor variants do not, therefore, seem to be major genetic determinants for the development of primary hyperparathyroidism. The variant A986S may possibly represent a risk factor for the development of parathyroid neoplasia in men. Moreover, the presence of the genotype Q1011E might influence the clinical course of the disease. The previously reported significant correlation of serum calcium levels with the genetic variant A986S in healthy subjects could not be confirmed.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Scillitani, V. Guarnieri, C. Battista, S. De Geronimo, L. A. Muscarella, I. Chiodini, M. Cignarelli, S. Minisola, F. Bertoldo, C. M. Francucci, et al.
Primary Hyperparathyroidism and the Presence of Kidney Stones Are Associated with Different Haplotypes of the Calcium-Sensing Receptor
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S Corbetta, C Eller-Vainicher, M Filopanti, P Saeli, G Vezzoli, T Arcidiacono, P Loli, M L Syren, L Soldati, P Beck-Peccoz, et al.
R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism.
Eur. J. Endocrinol., November 1, 2006; 155(5): 687 - 692.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
U. Peters, N. Chatterjee, M. Yeager, S. J. Chanock, R. E. Schoen, K. A. McGlynn, T. R. Church, J. L. Weissfeld, A. Schatzkin, and R. B. Hayes
Association of Genetic Variants in the Calcium-Sensing Receptor with Risk of Colorectal Adenoma
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2181 - 2186.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Scillitani, V. Guarnieri, S. De Geronimo, L. A. Muscarella, C. Battista, L. D'Agruma, F. Bertoldo, C. Florio, S. Minisola, G. N. Hendy, et al.
Blood Ionized Calcium Is Associated with Clustered Polymorphisms in the Carboxyl-Terminal Tail of the Calcium-Sensing Receptor
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5634 - 5638.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Vezzoli, A. Tanini, L. Ferrucci, L. Soldati, C. Bianchin, F. Franceschelli, C. Malentacchi, B. Porfirio, D. Adamo, A. Terranegra, et al.
Influence of Calcium-Sensing Receptor Gene on Urinary Calcium Excretion in Stone-Forming Patients
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2517 - 2523.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 European Society of Endocrinology.